Perrigo Company plc EBIT

The latest EBIT for PRGO is $-1.5B as of June 2026. That compares with $280M in the prior-year period — down 614.0% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Perrigo Company plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, PRGO's EBIT moved from $280M to $-1.5B — a 614.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Perrigo Company plc's operating scale or balance-sheet position.

Against Healthcare companies, PRGO currently prints $-1.5B for EBIT, while the sector average sits near $110B. That is roughly 101.4% below the sector mean. Large gaps often invite a closer look at Perrigo Company plc's growth, margins, and balance sheet.

A EBIT figure of $-1.5B for PRGO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting PRGO's EBIT ($-1.5B), review year-over-year change from $280M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.